Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page
- CheckyesterdayChange DetectedA new version entry was added on 2026-05-28 with updates to Study Status and Contacts/Locations (version 66 indicated for 2026-05-27); the 2026-02-27 entry was removed.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page's revision history updated to include a new entry labeled v3.5.4 and removed the previous v3.5.3 entry, indicating a backend revision to the documentation/versioning.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThis updates the displayed software/site revision from v3.5.2 to v3.5.3 on the ClinicalTrials.gov record history page.SummaryDifference0.0%

- Check44 days agoChange DetectedA new revision entry v3.5.2 was added, and the previous revision v3.5.0 was removed from the page history.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the history.SummaryDifference0.0%

- Check80 days agoChange DetectedFooter now displays Revision: v3.4.3, replacing Revision: v3.4.2 as part of a site update. This change does not affect study data or content on the page.SummaryDifference0.0%

Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.